Related Experiment Video
Updated: Jul 6, 2025

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
Published on: April 11, 2025
Glutamine addiction in tumor cell: oncogene regulation and clinical treatment
Xian Li1, Xueqiang Peng1, Yan Li1
1Department of General Surgery, The Fourth Affiliated Hospital, China Medical University, Shenyang, 110032, China.
Abstract:
After undergoing metabolic reprogramming, tumor cells consume additional glutamine to produce amino acids, nucleotides, fatty acids, and other substances to facilitate their unlimited proliferation. As such, the metabolism of glutamine is intricately linked to the survival and progression of cancer cells. Consequently, targeting the glutamine metabolism presents a promising strategy to inhibit growth of tumor cell and cancer development. This review describes glutamine uptake, metabolism, and transport in tumor cells and its pivotal role in biosynthesis of amino acids, fatty acids, nucleotides, and more. Furthermore, we have also summarized the impact of oncogenes like C-MYC, KRAS, HIF, and p53 on the regulation of glutamine metabolism and the mechanisms through which glutamine triggers mTORC1 activation. In addition, role of different anti-cancer agents in targeting glutamine metabolism has been described and their prospective applications are assessed.
Insights
Targeting cancer cell glutamine metabolism is a promising strategy. This review details glutamine
Area of Science:
- Oncology
- Cancer Metabolism
- Biochemistry
Background:
- Tumor cells reprogram metabolism, increasing glutamine consumption for proliferation.
- Glutamine metabolism is crucial for cancer cell survival and progression.
Purpose of the Study:
- To review glutamine metabolism in tumor cells.
- To explore its role in biosynthesis and cancer development.
- To assess anti-cancer agents targeting glutamine metabolism.
Main Methods:
- Literature review of glutamine metabolism in cancer.
- Summary of oncogene regulation (C-MYC, KRAS, HIF, p53) on glutamine metabolism.
- Analysis of glutamine's role in mTORC1 activation.
Main Results:
- Glutamine fuels biosynthesis of amino acids, nucleotides, and fatty acids.
- Oncogenes significantly regulate glutamine metabolism.
- Glutamine activates mTORC1 signaling pathway.
Conclusions:
- Targeting glutamine metabolism offers a viable anti-cancer strategy.
- Understanding glutamine's role is key for developing new cancer therapies.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment Resistant Cancers

